MDM2 promotor polymorphism and disease characteristics in CLL

被引:3
|
作者
Zenz, Thorsten [1 ]
Benner, Axel [2 ]
Stilgenbauer, Stephan [1 ]
机构
[1] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany
[2] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany
关键词
MDM2; CLL; SNP; CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; PATHWAY; SURVIVAL; PREDICTS; SNP309; CANCER; HUMANS;
D O I
10.1016/j.leukres.2009.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:578 / 579
页数:2
相关论文
共 50 条
  • [31] Impact of MDM2 309T>G polymorphism on sarcomagenesis
    Liu, Hua-Wei
    Ni, Ming
    Li, Xiang
    Chen, Hui
    Zhang, Guo-Qiang
    Chai, Wei
    Xu, Meng
    Zhou, Yong-Gang
    Chen, Ji-Ying
    Wang, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 12810 - 12817
  • [32] MDM2 SNP309 polymorphism is associated with colorectal cancer risk
    Weizhi Wang
    Mulong Du
    Dongying Gu
    Lingjun Zhu
    Haiyan Chu
    Na Tong
    Zhengdong Zhang
    Zekuan Xu
    Meilin Wang
    Scientific Reports, 4
  • [33] MDM2 309T>G polymorphism in human sarcomas
    Biason, P.
    Masier, S.
    Serra, M.
    Scotlandi, K.
    Cecchin, E.
    Sartor, F.
    Biscontin, G.
    Toffoli, G.
    EJC SUPPLEMENTS, 2006, 4 (12): : 180 - 181
  • [34] Association of MDM2 Polymorphism with Risk and Prognosis of Leukemia: A Meta-Analysis
    He, Xuepeng
    Chen, Peng
    Yang, Kai
    Liu, Bing
    Zhang, Yuan
    Wang, Fang
    Guo, Zhi
    Liu, Xiaodong
    Lou, Jinxing
    Chen, Huiren
    ACTA HAEMATOLOGICA, 2015, 133 (04) : 365 - 371
  • [35] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Manuela Argentini
    Nadia Barboule
    Bohdan Wasylyk
    Oncogene, 2001, 20 : 1267 - 1275
  • [36] MDM2 gene promoter polymorphism and risk of cervical cancer in Chinese population
    Jiang, Pei
    Liu, Jianxin
    Zeng, Xiaoxi
    Li, Wen
    Tang, Jianxin
    2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2010), 2010,
  • [37] MDM2 T309G polymorphism is associated with bladder cancer
    Onat, O. E.
    Tez, M.
    Ozcelik, T.
    Toruner, G. A.
    FEBS JOURNAL, 2006, 273 : 225 - 226
  • [38] MDM2 T309G polymorphism is associated with bladder cancer
    Onat, Onur Emre
    Tez, Mesut
    Ozcelik, Tayfun
    Toruner, Gokce A.
    ANTICANCER RESEARCH, 2006, 26 (5A) : 3473 - 3475
  • [39] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [40] MDM2 SNP309 polymorphism is associated with colorectal cancer risk
    Wang, Weizhi
    Du, Mulong
    Gu, Dongying
    Zhu, Lingjun
    Chu, Haiyan
    Tong, Na
    Zhang, Zhengdong
    Xu, Zekuan
    Wang, Meilin
    SCIENTIFIC REPORTS, 2014, 4